Fact CheckerSign in

NCT07043153Recruiting

AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity

Using Combination of Albumin to Globulin Ratio and Prognostic Nutritional Index Model for Predicting Disease Activity in Patients With Systemic Lupus Erythematosus

Source: ClinicalTrials.gov · Last updated 13 May 2026

Brief summary (registry, in English)

This study aims to evaluate the clinical utility of combining the albumin to globulin ratio (AGR) and the prognostic nutritional index (PNI) as a predictive model for assessing disease activity in patients with systemic lupus erythematosus (SLE). By correlating these nutritional and inflammatory markers with clinical manifestations and laboratory parameters, we hope to establish a simple, non-invasive, and cost-effective tool to aid in monitoring disease activity in Systemic lupus erythematosus patients.

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
19 Jun 2025
Start date
5 Aug 2025
Primary completion date
30 Jun 2026
Lead sponsor
Sohag University
Diseases
Lupus (SLE)
NCT number
NCT07043153

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 5 Aug 2025 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Acute infection within the previous four weeks

Other illness

  • Co-existing chronic inflammatory or autoimmune diseases.
  • Malignancy.
  • Chronic liver or renal insufficiency.
  • Malignant hematologic diseases.
  • Active hepatitis.

Age

  • Age \<18 years

Other

  • Pregnancy or lactation.

Who the study is looking for

  • · Age ≥ 18 years.
    • Both sexes.
    • Patients diagnosed with SLE who fulfilling the Systemic Lupus International Collaborating Clinics (SLICC) classification criteria and matched controls.

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sohag university hospitals
Coordinator of this site? Confirm its status
SohagEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.